Patents Assigned to Grace Laboratories Inc.
  • Patent number: 7820398
    Abstract: Immunosorbents, kits and compositions for diagnosing a central nervous system disorder, particularly paroxysmal cerebral discharges and epilepsy, comprising measuring the concentration of GluR1 or fragment thereof and/or GluR1 antibodies in a biological sample from a human subject. The method is particularly useful for identifying individuals that are at risk for brain related seizures and epilepsy, for distinguishing epilepsy from pseudo-epilepsy and epilepsy-like disorders, for following up after anticonvulsive treatment, and for the adjustment of adequate therapy and doses.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: October 26, 2010
    Assignee: Grace Laboratories Inc.
    Inventors: Svetlana A. Dambinova, Galina Izykenova
  • Publication number: 20050181466
    Abstract: Immunosorbents, kits and compositions for diagnosing a central nervous system disorder, particularly paroxysmal cerebral discharges and epilepsy, comprising measuring the concentration of GluR1 or fragment thereof and/or GluR1 antibodies in a biological sample from a human subject. The method is particularly useful for identifying individuals that are at risk for brain related seizures and epilepsy, for distinguishing epilepsy from pseudo-epilepsy and epilepsy-like disorders, for following up after anticonvulsive treatment, and for the adjustment of adequate therapy and doses.
    Type: Application
    Filed: November 8, 2004
    Publication date: August 18, 2005
    Applicant: Grace Laboratories, Inc.
    Inventors: Svetlana Dambinova, Galina Izykenova